97231-90-8

Usage

Uses

Used in Pharmaceutical Industry:
3-Piperidinecarboxylic acid benzyl ester is used as a building block for the synthesis of various pharmaceuticals and agrochemicals. Its structural properties and potential biological activity make it a valuable component in the development of new drugs and therapeutic agents.
Used in Organic Synthesis:
3-Piperidinecarboxylic acid benzyl ester is used as a stable intermediate in organic synthesis. The benzyl ester group provides stability, allowing for further reactions and modifications to create a wide range of chemical compounds.
Used in Production of Fine Chemicals and Pharmaceutical Intermediates:
3-Piperidinecarboxylic acid benzyl ester is used as a key component in the production of fine chemicals and pharmaceutical intermediates. Its versatility and stability make it an essential ingredient in the synthesis of various specialty chemicals and intermediates used in the pharmaceutical industry.

InChI:InChI=1/C13H17NO2/c15-13(12-7-4-8-14-9-12)16-10-11-5-2-1-3-6-11/h1-3,5-6,12,14H,4,7-10H2

Upstream product

• 139985-95-8 piperidine-1,3-dicarboxylic acid 3-benzyl ester 1-tert-butyl ester 
• 97231-84-0 Piperidine-1,3-dicarboxylic acid dibenzyl ester 

Downstream Products

• 939410-76-1 benzyl 1-(pyridin-2-yl)piperidine-3-carboxylate 
• 939410-75-0 benzyl 1-cyclopentylpiperidine-3-carboxylate 
• 269068-44-2 (+/-)-1-[5-(2-Adamantan-1-yl-ethyl)-2-o-tolyl-1H-imidazole-4-carbonyl]-piperidine-3-carboxylic Acid 

Relevant academic research and scientific papers

NOVEL CYCLIC AMINOBENZOIC ACID DERIVATIVE

The present invention relates to cyclic amino benzoic acid derivatives which are effective in therapy of lipid metabolism abnormality, diabetes and the like as a human peroxisome proliferators-activated receptor (PPAR) agonist, in particular, as an agonist against human PPARα isoform, and addition salts thereof, and pharmaceutical compositions containing these compounds. A cyclic amino benzoic acid derivative represented by the general formula (1) [wherein a ring Ar represents an aryl group which may have substituent, or the like; Y represents a C1-C4 alkylene, C2-C4 alkenylene, C2-C4 alkynylene, or the like; Z represents an oxygen atom, sulfur atom or - (CH2)n- (n represents 0,1 or 2) ; X represents a hydrogen atom, halogen atom, lower alkyl group which may be substituted with a halogen atom, or the like; R represents a hydrogen atom or lower alkyl group, and -COOR substitutes for an ortho position or metha position of binding position of ring W] or a pharmaceutically acceptable salt thereof.

BETA-SECRETASE MODULATORS AND METHODS OF USE

The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula I wherein A, B, R3, R4, R5, i and j are defined herein. The invention also comprises pharmaceutical compositions including one or more compounds of Formula I, methods of use for these compounds, including treatment of AD and related diseases, by administering the compound(s) of Formula I, or compositions including them, to a subject. The invention also comprises further embodiments of Formulas II and III, intermediates and processes useful for the preparation of compounds of the invention.

Acetyl-CoA carboxylase inhibitors

Acetyl Coenzyme A Carboxylase inhibitors, pharmaceutical compositions containing such compounds and the use of such compounds to treat for example, Metabolic Syndrome including atherosclerosis, diabetes and obesity.

CATECHOL BORON HALIDES: MILD AND SELECTIVE REAGENTS FOR CLEAVAGE OF COMMON PROTECTING GROUPS

Catechol boron halides (1,X=Cl,Br) cleave certain ether, ester and carbamate protecting groups under mild conditions.The scope and selectivity of these readily available reagents has been examined.